Related Experiment Video
Updated: Feb 24, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
pH-Dependent Conformational Changes in Grb2 Monomer Reveal Different Binding Sites for Coumarin: An Insight for Small
Giovana Casteluci1,2, Raphael Vinicius Rodrigues Dias1,2, Jéssica Andrade Tedesco1,2
1Department of Physics, São Paulo State University (UNESP), Institute of Biosciences, Humanities and Exact Sciences, 15054-000 São José do Rio Preto, SP Brazil.
Abstract:
Growth factor receptor-bound protein 2 (Grb2) is an essential adaptor protein that mediates activation of the RAS/mitogen-activated protein kinase (MAPK) signaling cascade by linking receptor tyrosine kinase to the guanine nucleotide exchange factor SOS (Son of Sevenless). Grb2 exists in a dynamic monomer-dimer equilibrium, with only the monomer competent for signaling. Dysregulation of this pathway is common in cancer, making Grb2 a compelling therapeutic target. Coumarin, a plant-derived compound with reported anticarcinogenic activity, was previously shown to bind the SH2 domain of dimeric Grb2. Here, we investigated the interaction between coumarin and the monomeric form of Grb2 under two physiologically relevant pH conditions (7 and 8), corresponding to healthy and cancer cell environments, respectively. Fluorescence quenching, dynamic light scattering, and STD-NMR analyses revealed that pH modulates Grb2's conformation, increasing its hydrodynamic diameter and exposing alternative ligand-binding sites. The interaction mapping identified Trp60 (buried in the dimeric form) as a key contact residue and at pH 8.0, coumarin binds Grb2 with a 10-fold higher stability. These findings demonstrate, for the first time, that coumarin interacts with monomeric Grb2 and that pH-sensitive structural dynamics modulate ligand binding. Our results highlight the importance of mimicking disease-relevant physicochemical conditions in ligand discovery efforts and support the development of pH-sensitive inhibitors targeting aberrant MAPK signaling in cancer.
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
Drug-Receptor Bonds
In...

